FP7H2020HORIZON
Medizinische Hochschule Hannover
- Country
- DEGermany
- Defence projects
- 0
- Projects, all programmes
- 122
- As coordinator
- 32
- EU contribution (CORDIS)
- EUR 58,114,474
- Active
- 2008 to 2025
Projects
122 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| MIGRATeMolecular Imaging to Guide Repair and Advance Therapy: Targeting the inflammation-fibrosis axis in ischemic heart disease and remote organs | HORIZON | 2025 | Coordinator | EUR 1,933,148 |
| KSHV-RBPomeElucidating the role of RNA-binding proteins in Kaposi’s sarcoma-associated herpesvirus infected cells during latency-reactivation switches | HORIZON | 2024 | Coordinator | EUR 189,687 |
| iMAClungMoving cell-based immunotherapies to fight bacterial lung infections into the clinics | HORIZON | 2024 | Coordinator | EUR 150,000 |
| MAGICNext-generation models and genetic therapies for rare neuromuscular diseases | HORIZON | 2023 | Participant | EUR 980,875 |
| IntReALL 2020International Study for Treatment of Childhood Relapsed ALL 2020 | HORIZON | 2023 | Participant | EUR 93,750 |
| IMPACT- AMLMaster Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia | HORIZON | 2023 | Participant | EUR 875 |
| iPYROCustom-Made Designer Macrophages to Revolutionize the Safety of Parenteral Drugs | HORIZON | 2023 | Coordinator | EUR 150,000 |
| HEALHLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart | HORIZON | 2022 | Coordinator | EUR 1,396,250 |
| DecipherHSVDeciphering cellular and viral determinants of lytic HSV-1 infection, latency and reactivation | HORIZON | 2022 | Coordinator | EUR 1,421,350 |
| READIHEARRehabilitation and Diagnosis of Hearing Loss based on Electric Acoustic Interaction | HORIZON | 2022 | Coordinator | EUR 1,978,875 |
| FIBREXTargeting cardiac fibrosis with next generation RNA therapeutics | HORIZON | 2022 | Coordinator | EUR 2,499,482 |
| REVERSECircular RNAs to reverse pathological remodelling of the injured heart | HORIZON | 2022 | Coordinator | EUR 2,499,375 |
| MY-O-SENSESPre-clinical development of a lentiviral gene therapy to treat hearing and balance loss in Usher 1B patients | HORIZON | 2022 | Coordinator | EUR 150,000 |
| RETENTIONheaRt failurE paTient managEment and iNTerventIOns usiNg continuous patient monitoring outside hospitals and real world data | H2020 | 2021 | Participant | EUR 527,442 |
| Comm4CHILDCommunication for Children with Hearing Impairment to optimise Language Development | H2020 | 2020 | Participant | EUR 252,788 |
| LiverScreenScreening for liver fibrosis - population-based study across European countries | H2020 | 2020 | Participant | EUR 190,000 |
| iPSC2TherapyFrom iPSC-Macrophage Biology Towards Regenerative Therapies Targeting Respiratory Infections | H2020 | 2020 | Coordinator | EUR 1,499,100 |
| MEGFIBNoncoding RNA MEG3 inhibitor for Heart Failure Treatment | H2020 | 2020 | Coordinator | EUR 150,000 |
| ESCALONEuropean-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development | H2020 | 2019 | Participant | EUR 145,000 |
| CardioReGenixCardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease | H2020 | 2019 | Participant | EUR 1,193,623 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.